These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 12599289
1. Intraoperative radiotherapy for head and neck and skull base cancer. Pinheiro AD, Foote RL, McCaffrey TV, Kasperbauer JL, Bonner JA, Olsen KD, Cha SS, Sargent DJ. Head Neck; 2003 Mar; 25(3):217-25; discussion 225-6. PubMed ID: 12599289 [Abstract] [Full Text] [Related]
2. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience. Ling SM, Roach M, Fu KK, Coleman C, Chan A, Singer M. Cancer J Sci Am; 1996 Mar; 2(6):321-9. PubMed ID: 9166552 [Abstract] [Full Text] [Related]
4. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE. Head Neck; 2004 May 01; 26(5):447-55. PubMed ID: 15122662 [Abstract] [Full Text] [Related]
5. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, Pestalozzi B, Schmid S, Thöni A, Ozsahin M, Bernier J, Töpfer M, Kann R, Meier UR, Thum P, Bieri S, Notter M, Lombriser N, Glanzmann C. J Clin Oncol; 2004 Dec 01; 22(23):4665-73. PubMed ID: 15534360 [Abstract] [Full Text] [Related]
6. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer. Perry DJ, Chan K, Wolden S, Zelefsky MJ, Chiu J, Cohen G, Zaider M, Kraus D, Shah J, Lee N. Int J Radiat Oncol Biol Phys; 2010 Mar 15; 76(4):1140-6. PubMed ID: 19560882 [Abstract] [Full Text] [Related]
7. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results. Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E. Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569 [Abstract] [Full Text] [Related]
8. Intraoperative radiation therapy as an "early boost" in locally advanced head and neck cancer: preliminary results of a feasibility study. Marucci L, Pichi B, Iaccarino G, Ruscito P, Spriano G, Arcangeli G. Head Neck; 2008 Jun 01; 30(6):701-8. PubMed ID: 18286497 [Abstract] [Full Text] [Related]
9. Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage. Al-Othman MO, Mendenhall WM, Amdur RJ. Am J Otolaryngol; 2001 Jun 01; 22(6):387-90. PubMed ID: 11713722 [Abstract] [Full Text] [Related]
10. [Carcinoma of the oropharynx extended to the base of the tongue: radiosurgical treatment with intraoperative radiotherapy]. Schmitt T, Prades J, Pinto N, Puel G, Barbet N, Calloc'h F. Bull Cancer Radiother; 1996 Jun 01; 83(2):79-85. PubMed ID: 8688223 [Abstract] [Full Text] [Related]
11. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT. Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):410-21. PubMed ID: 16168834 [Abstract] [Full Text] [Related]
12. Value of postoperative radiotherapy in patients with pathologic N1 neck disease. Jäckel MC, Ambrosch P, Christiansen H, Martin A, Steiner W. Head Neck; 2008 Jul 01; 30(7):875-82. PubMed ID: 18302275 [Abstract] [Full Text] [Related]
13. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer. Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE. Head Neck; 2004 Jul 01; 26(7):561-72. PubMed ID: 15229898 [Abstract] [Full Text] [Related]
14. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS. Head Neck; 2004 May 01; 26(5):389-95. PubMed ID: 15122654 [Abstract] [Full Text] [Related]
15. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer. Zouhair A, Azria D, Pasche P, Stupp R, Chevalier J, Betz M, Mirimanoff RO, Ozsahin M. Radiother Oncol; 2004 Feb 01; 70(2):183-8. PubMed ID: 15028406 [Abstract] [Full Text] [Related]
16. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR. Cancer; 2005 Oct 01; 104(7):1408-17. PubMed ID: 16130134 [Abstract] [Full Text] [Related]
17. Planned post-chemoradiation neck dissection: significance of radiation dose. Stenson KM, Huo D, Blair E, Cohen EE, Argiris A, Haraf DJ, Vokes EE. Laryngoscope; 2006 Jan 01; 116(1):33-6. PubMed ID: 16481805 [Abstract] [Full Text] [Related]
18. Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy. Prabhu R, Hinerman RW, Indelicato DJ, Morris CG, Werning JW, Vaysberg M, Amdur RJ, Kirwan J, Mendenhall WM. Am J Clin Oncol; 2009 Aug 01; 32(4):401-4. PubMed ID: 19398900 [Abstract] [Full Text] [Related]
20. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Katori H, Tsukuda M, Watai K. Cancer Chemother Pharmacol; 2007 Aug 01; 60(3):399-406. PubMed ID: 17096160 [Abstract] [Full Text] [Related] Page: [Next] [New Search]